Grindeks AS (Grindeks JSC) is a Latvia-based joint stock company engaged in the pharmaceutical sector. The Company is engaged in the production of pharmaceutical and medical products, and phytochemical medicine. The Company offers products, such as: ointments, cough and cold medications, anti-inflammatory agents, gastroenterological agents, tonics and natural health products, as well as active pharmaceutical substances. The Company's research activities are mainly focused towards the development of cardiovascular medications, neurological medications, anti cancer agents and antiviral drugs. The Company is active domestically and abroad, mainly in the Commonwealth of Independent State countries. It also owns four subsidiaries, Tallin Pharmaceutical Plant JSC, Namu Apsaimniekosanas projekti Ltd, Grindeks RUS Ltd and Kalceks JSC. As of December 31, 2011, the Company's major corporate shareholder was AB.LV Private Equity Fund 2010, with a stake of 11.38%.

Pharmaceutical

Grindeks

This department oversees various operational and strategic functions within the organization to ensure effective leadership and resource allocation.

Management Services

This department oversees operations and strategy within designated geographical areas.

Regional Management

This department is responsible for ensuring compliance with regulations and managing the approval process for products and services.

Regulatory Affairs

This department focuses on managing key customer relationships to ensure satisfaction and foster long-term business connections.

Account Management

This department focuses on managing product offerings, marketing strategies, and sales activities to drive business growth.

Commercial Operations

This department ensures that products meet quality standards and regulatory requirements throughout the supply chain.

People (10)

Jobs (0)

Other teams

Regional Management

Regulatory Affairs

Account Management

Commercial Operations

Quality Assurance